SPL 1.03% 9.6¢ starpharma holdings limited

Ann: DEP outperforms leading treatments in ovarian cancer model, page-8

  1. 3,314 Posts.
    lightbulb Created with Sketch. 780
    Pre-clinical results from DEP-HER2 ADC in 2015.

    "We are very excited by these latest results for our targeted DEP ™ conjugates and feedback from commercial parties on this new data has been very positive indeed. Discussions are now underway with a number of pharmaceutical companies in relation to this targeted DEP conjugate …”

    Meanwhile, almost 9 years later ….


    Last edited by sarge17: 31/05/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
-0.001(1.03%)
Mkt cap ! $39.58M
Open High Low Value Volume
9.6¢ 9.7¢ 9.6¢ $1.473K 15.24K

Buyers (Bids)

No. Vol. Price($)
2 43942 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 2221 2
View Market Depth
Last trade - 11.32am 10/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.